ESMO

Rybrevant Plus Chemo Results in Superior Outcomes in EGFR-Mutant Advanced NSCLC

September 14th 2024, 4:34pm

Article

Rybrevant plus chemotherapy improved overall survival versus chemo alone in EGFR-mutant advanced non-small cell lung cancer after disease progression.

Enhertu Demonstrates Overall, Intracranial Activity in HER2-Positive Breast Cancer

September 13th 2024, 10:00pm

Article

Patients with HER2-positive breast cancer benefitted from treatment with Enhertu regardless of brain metastasis.

Welireg Shows Stable Survival Benefits Over Afinitor in Kidney Cancer

September 13th 2024, 9:00pm

Article

Among patients with previously treated advanced clear cell renal cell carcinoma (RCC) Welireg continued to show some benefits, though not to overall survival.

Imfinzi After Primary Treatment Does Not Improve Disease-Free Survival in PD-L1-Positive NSCLC

September 13th 2024, 7:00pm

Article

Patients with NSCLC did not see a disease-free survival benefit with Imfinzi after surgery compared with taking a placebo.

Velcade and Rituxan Help Improve Responses in Marginal Zone Lymphoma

November 24th 2023, 2:00pm

Article

A treatment combination that includes Velcade and Rituxan helps improve responses and the safety profile in marginal zone lymphoma, according to a phase 2 trial.

Dato-DXd Led To Antitumor Activity in Some Patients With Pretreated NSCLC

November 23rd 2023, 3:00pm

Article

Datopotamab deruxtecan elicited encouraging responses in patients with heavily pretreated non–small cell lung cancer harboring actionable genomic alterations.

Welireg Plus Cabometyx Shows Anti-Tumor Activity in Kidney Cancer Type

November 22nd 2023, 11:00pm

Article

The Welireg-Cabometyx treatment combination demonstrated anti-tumor activity for some patients with clear cell renal carcinoma, according to a phase 2 trial.

Cancer Vaccine Plus Keytruda Improves Survival Without Relapse in Resected Melanoma

November 7th 2023, 2:00pm

Article

Findings from a phase 2 trial showed improvements in relapse-free survival with an mRNA vaccine plus Keytruda compared with Keytruda alone in patients with high-risk resected melanoma.

Trodelvy May Provide Benefits in Extensive-Stage Small Cell Lung Cancer

November 5th 2023, 10:00pm

Article

Patients with extensive-stage small cell lung cancer responded well to the treatment of Trodelvy, according to preliminary results from a phase 2 trial.

Lifileucel Is Efficacious in Advanced Mucosal Melanoma

October 30th 2023, 10:00pm

Article

A phase 2 study evaluated meaningful activity from lifileucel for patients with advanced mucosal melanoma who experienced disease progression on immune checkpoint inhibitors.